VIIV EXODUS OF EMPLOYEES

[anonymous]

I hope you are right, because they sure the hell aren’t using 2DR for treatment

Don’t worry, Sparky. I’m sure the geniuses here will bypass us the opportunity to actually sell something our customers might use in favor of another unnecessary sales force.

 

[anonymous]

Its one shot and superior data and doctors and w want it

pills don’t work that well because people don’t take them- especially with this 2,1,1 oh just 4 day a week or don’t worry about 7 days a week push. That seems like more irresponsible Gilead bullshit

Laughable!!! More ViiV reaching tactics! What a disgrace of a company it has become. ViiV currently exists only to muddy the waters because its products SUCK and their only offering to customers is about how Gilead products are bad. Dovato has a 3% share, Juluca about a 2.5% share and CAB’s share isn’t even a tenth of a percent. That’s PATHETIC performance! ViiV’s last three launches have to be among the worst in pharma history. Odefsey, that’s right Odefsey has a higher market share than CAB, Juluca and Dovato combined. Odefsey!?!?!?! Maybe ViiV should start REALLY trying to convince providers why its products are superior instead of throwing sh!t on the wall about Gilead’s to see if it sticks.

 

[anonymous]

I heard today that even with the amount of people leaving on their own, the powers that be have looked at the Dovato and Cab performance and determined layoffs are necessary. Can anyone confirm, tell us what percent will be let go, when, and from which team?

 

[anonymous]

I heard today that even with the amount of people leaving on their own, the powers that be have looked at the Dovato and Cab performance and determined layoffs are necessary. Can anyone confirm, tell us what percent will be let go, when, and from which team?

I’m in house and can confirm this - trying to decide who to keep, who to cut, and territory makeup

 

[anonymous]

Start with FINK and her AVP’s
Then Waterhouse and Andrew P

 

[anonymous]

Sanofi and Novartis call this the Fink fallout

Its astonishing that Fink who after a complete disaster of a career at Sanofi and then finally fired was hired by Novartis and fired after 14 months was hired into ViiV. How she survived this long at ViiV with her incompetence level at an all time high is beyond me. She's a finger pointer extraordinaire who's a disgrace to any organization that employees her. Novartis and Sanofi knew when they were FINKED!

 

[anonymous]

I heard today that even with the amount of people leaving on their own, the powers that be have looked at the Dovato and Cab performance and determined layoffs are necessary. Can anyone confirm, tell us what percent will be let go, when, and from which team?

Get that resume out there. GSK is crap and you will be happier when you’re out.

 

[anonymous]

Get that resume out there. GSK is crap and you will be happier when you’re out.

All the tokens will be promoted then

 

[anonymous]

All the tokens will be promoted then

You mean like Fink, right?

 

[anonymous]

Honest responses would be appreciated. I have interview scheduled but considering withdrawing after what I’ve read here & heard. Now I see ViiV hiring through Syneos. Are they hiring both for ViiV and contract, copromotion? Recruiter didn’t give a lot of info.

 

[anonymous]

Honest responses would be appreciated. I have interview scheduled but considering withdrawing after what I’ve read here & heard. Now I see ViiV hiring through Syneos. Are they hiring both for ViiV and contract, copromotion? Recruiter didn’t give a lot of info.

What I’ve heard internally is the 3 HIV products they have launched in the last 3-4 years have underperformed so massively (to the tune of billions under expectations) that they are actually fine with people leaving. They are trying to right size without layoffs to reduce cost. New hires like yourself would be put in territories that have lost multiple people. It would not be a surprise if selling Dovato/Juluca became contract sales as they are losing money hand over fist.

 

[anonymous]

What I’ve heard internally is the 3 HIV products they have launched in the last 3-4 years have underperformed so massively (to the tune of billions under expectations) that they are actually fine with people leaving. They are trying to right size without layoffs to reduce cost. New hires like yourself would be put in territories that have lost multiple people. It would not be a surprise if selling Dovato/Juluca became contract sales as they are losing money hand over fist.

They made their bed.........

 

[anonymous]

Load of crap. They would not be hiring a PrEp team if they were planning layoffs. The company loves to spend money (waist). Maybe a year after PrEP fails they will move to layoffs. So we all have at least another 2 years

 

[anonymous]

Load of crap. They would not be hiring a PrEp team if they were planning layoffs. The company loves to spend money (waist). Maybe a year after PrEP fails they will move to layoffs. So we all have at least another 2 years

Then they are CLUELESS about PrEP. For a myriad of reasons.

 

[anonymous]

Then they are CLUELESS about PrEP. For a myriad of reasons.

These are the same people who hired a ton of people to sell Dovato, a dog of a drug worth crumbs versus Triumeq. They also hired a ton of people to sit around and “prepare the market” for a year for Cab - an even bigger disaster.

 

[anonymous]

These are the same people who hired a ton of people to sell Dovato, a dog of a drug worth crumbs versus Triumeq. They also hired a ton of people to sit around and “prepare the market” for a year for Cab - an even bigger disaster.

The crumbs you’re mother sold to get you you’re job?

 

[anonymous]

The crumbs you’re mother sold to get you you’re job?

In the context of your use of 'you're' BOTH TIMES, it should actually be 'YOUR' not too bright yourself, dumbass.

 

[anonymous]

In the context of your use of 'you're' BOTH TIMES, it should actually be 'YOUR' not too bright yourself, dumbass.

Probably a Cab “expert” at .1% market share

 

[anonymous]

Its one shot and superior data and doctors and w want it

pills don’t work that well because people don’t take them- especially with this 2,1,1 oh just 4 day a week or don’t worry about 7 days a week push. That seems like more irresponsible Gilead bullshit

What a dumb post! Of course pills work. There’s >99% efficacy when Descovy is taken 7 days/week, 96% effective when taken 4 days per week. Sounds like more irresponsible ViiV bullshit!

 

[anonymous]

Its one shot and superior data and doctors and w want it

pills don’t work that well because people don’t take them- especially with this 2,1,1 oh just 4 day a week or don’t worry about 7 days a week push. That seems like more irresponsible Gilead bullshit

I would agree with this. People do skip pills. This is why we are seeing so much Dovato resistance out there. People skip a dose or two and they blow the drug up.